Gene therapy of cancer : methods and protocols /
Saved in:
| Edition: | 2nd ed. |
|---|---|
| Imprint: | New York, NY : Humana, c2009. |
| Description: | xiv, 731 p., [8] p. of plates : ill. (some col.) ; 27 cm. |
| Language: | English |
| Series: | Methods in molecular biology, 1064-3745 ; 542 Methods in molecular biology (Clifton, N.J.) ; v. 542. |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/7714661 |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | 7714661 | ||
| 005 | 20090616132400.0 | ||
| 008 | 090213s2009 nyu 001 0 eng d | ||
| 003 | ICU | ||
| 010 | |a 2008942247 | ||
| 016 | 7 | |a 101503033 | |
| 020 | |a 1934115851 | ||
| 020 | |a 9781934115855 | ||
| 020 | |a 9781597455619 (e-ISBN) | ||
| 020 | |a 159745561X (e-ISBN) | ||
| 035 | |a (OCoLC)305125265 | ||
| 040 | |a YDXCP |c YDXCP |d PAU |d CUS |d NLM |d CDX |d COU | ||
| 049 | |a CGUA | ||
| 050 | 4 | |a QH506 |b .M45 v.542 2009 | |
| 060 | 0 | 0 | |a W1 |b ME9616J v.542 2009 |
| 060 | 1 | 0 | |a QZ 266 |b G3259 2009 |
| 082 | 0 | 4 | |a 616.99/4042 |2 22 |
| 245 | 0 | 0 | |a Gene therapy of cancer : |b methods and protocols / |c edited by Wolfgang Walther and Ulrike S. Stein. |
| 250 | |a 2nd ed. | ||
| 260 | |a New York, NY : |b Humana, |c c2009. | ||
| 300 | |a xiv, 731 p., [8] p. of plates : |b ill. (some col.) ; |c 27 cm. | ||
| 336 | |a text |b txt |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
| 337 | |a unmediated |b n |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/n | ||
| 338 | |a volume |b nc |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/nc | ||
| 490 | 1 | |a Methods in molecular biology, |x 1064-3745 ; |v 542 | |
| 500 | |a "Springer protocols"--cover. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Section 1. Experimental approaches in cancer therapy -- 1. Development of gene therapy / Jean-Pierre Gillet, ... [et al.] -- Subsection B -- Vectorology for cancer gene therapy -- 2. Designing adenoviral vectors for tumor-specific targeting / Ramon Alemany -- 3. Analysis of HSV oncolytic virotherapy in organotypic cultures / Giulia Fulci, Brent Passer -- 4. Use of minicircle plasmids for gene therapy / Peter Mayrhofer, Martin Schleef, Wolfgang Jechlinger -- 5. Transposable elements as plasmid-based vectors for long-term gene transfer into tumors / John R. Ohlfest, Zoltán Ivics, Zsuzsanna Izsvák -- 6. Designing plasmid vectors / Oleg Tolmachov -- 7. Development of bacterial vectors for tumor-targeted gene therapy / Li-Jun Jia and Zi-Chun Hua -- Subsection C Nonviral transfer technologies in cancer gene therapy -- 8. Electroporative gene transfer / Marco Schmeer -- 9. Gene gun delivery systems for cancer vaccine approaches / Kandan Aravindaram and Ning Sun Yang -- 10. Ultrasound-mediated gene transfection / Loreto B. Feril Jr. -- 11. Nonviral jet-injection technology for intratumoral in vivo gene transfer of naked DNA / Wolfgang Walther ... [et al.] -- Subsection D: Experimental studies in cancer gene therapy -- 12. Methods for constructing and evaluating antitumor DNA vaccines / Brian M. Olson and Douglas G. McNeel -- 13. Immunity of lentiviral vector-modified dendritic cells / Shuhong Han and Lung-Ji Chang -- 14. Saporin suicide gene therapy / Natasa Zarovni, Riccardo Vago, and Maria Serena Fabbrini -- 15. Using in vivo biopanning for the development of radiation-guided drug delivery systems / Jerry J. Jaboin, Zhaozhong Han, and Dennis E. Hallahan -- 16. Chemosensitization of Tumor Cells: Inactivation of nuclear factor-kappa B associated with chemosensitivity in melanoma cells after combination treatment with E2F-1 and doxorubicin / Hongying Hao, H. Sam Zhou, and Kelly M. McMasters -- 17. Induction of tumor cell apoptosis by TRAIL gene therapy / Thomas S. Griffith -- 18. Silencing epidermal growth factor receptor by RNA interference in glioma / Chunsheng Kang, Peiyu Pu, and Hao Jiang -- 19. Delivery of phosphorodiamidate morpholino antisense oligomers in cancer cells / Gayathri R. Devi -- 20. Use of RNA aptamers for the modulation of cancer cell signaling / Sunjoo Jeong, Hee Kyu Lee, and Mee Young Kim -- 21. G-rich oligonucleotides for cancer treatment / Paula J. Bates, Enid W. Choi, and Lalitha V. Nayak -- | |
| 505 | 0 | |a Section 2. Clinical approaches in cancer gene therapy -- Subsection A. Requirements for clinical gene therapy trials -- 22. Regulatory aspects for translating gene therapy research into the clinic / Carolyn M. Laurencot and Sheryl Ruppel -- 23. Ethics of cancer gene transfer clinical research / Jonathan Kimmelman -- 24. Virus production for clinical gene therapy / Tiago Vicente, ... [et al.] -- 25. Production of plasmid DNA as pharmaceutical / Martin Schleef and Markus Blaesen --Subsection B. Clinical protocols in cancer gene therapy -- 26. Gene immunotherapy for non-small cell lung cancer / John J. Nemunaitis -- 27. Gene therapy for antitumor vaccination / Seunghee Kim-Schulze and Howard L. Kaufman -- 28. HSV-tk/IL-2 gene therapy for glioblastoma multiforme / Luisa Barzon, ... [et al.] -- 29. Construction and characterization of an oncolytic HSV vector containing a fusogenic glycoprotein and prodrug activation for enhanced local tumor control / Guy R. Simpson and Robert S. Coffin -- 30. Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer / Volker Schirrmacher and Philippe Fournier -- 31. Oncolytic viral therapy using reovirus / Chandini Thirukkumaran and Don G. Morris -- 32. Design and testing of novel oncolytic vaccinia strains / Steve H. Thorne -- 33. Tumor-targeted salmonella typhimurium overexpressing cytosine deaminase: a novel, tumor-selective therapy / Ivan King, Martina Itterson, and David Bermudes -- 34. Chemoprotection by transfer of resistance genes / Tulin Budak-Alpdogan and Joseph R. Bertino -- 35. Phase I clinical trial of locoregional administration of the oncolytic adenovirus ONYX-015 in combination with mitomycin-C, doxorubicin, and cisplatin chemotherapy in patients with advanced sarcomas / Mateusz Opyrchal, Ileana Aderca, and Evanthia Galanis. | |
| 650 | 0 | |a Cancer |x Gene therapy |v Laboratory manuals. | |
| 650 | 1 | 2 | |a Neoplasms |x therapy. |
| 650 | 2 | 2 | |a Gene Therapy |x methods. |
| 650 | 7 | |a Cancer |x Gene therapy. |2 fast |0 http://id.worldcat.org/fast/fst00845367 | |
| 655 | 7 | |a Laboratory manuals. |2 fast |0 http://id.worldcat.org/fast/fst01920776 | |
| 700 | 1 | |a Walther, Wolfgang. |0 http://id.loc.gov/authorities/names/n99802328 |1 http://viaf.org/viaf/34629389 | |
| 700 | 1 | |a Stein, Ulrike. |0 http://id.loc.gov/authorities/names/n99802329 |1 http://viaf.org/viaf/24773303 | |
| 830 | 0 | |a Methods in molecular biology (Clifton, N.J.) ; |v v. 542. | |
| 901 | |a Analytic | ||
| 903 | |a HeVa | ||
| 929 | |a cat | ||
| 999 | f | f | |i 1a526b23-290f-5f93-af63-127c9a8b091d |s c66c585d-292b-5140-8301-fe0ba016d8fb |
| 928 | |t Library of Congress classification |a QH506.M45 v.542 |l ASR |c ASR-SciASR |i 5379246 | ||
| 927 | |t Library of Congress classification |a QH506.M45 v.542 |l ASR |c ASR-SciASR |g Analytic |e CRERAR |b A80428933 |i 8609300 | ||
